Related Experiment Videos
Irregular antibodies causing hemolytic disease of the newborn
Insights
This study details antigens causing hemolytic disease of the newborn and their severity. It aims to aid clinicians in managing irregular antibodies and predicting risks for future pregnancies.
Area of Science:
- Immunology
- Obstetrics
- Genetics
Background:
- Hemolytic disease of the newborn (HDN) is a significant concern in obstetrics.
- Management of HDN relies on identifying causative antigens and predicting disease severity.
- Irregular antibodies in antenatal patients pose a risk for HDN.
Purpose of the Study:
- To present known antigens associated with HDN and their severity.
- To provide genotype frequencies for major blood groups.
- To assist clinicians in managing irregular antibody sensitization and predicting risks for affected siblings.
Main Methods:
- Review and presentation of known antigens causing HDN and their associated disease severity (Table 13).
- Inclusion of genotype frequencies for major blood groups within the text.
- Discussion of clinical management strategies for antenatal patients with irregular antibodies.
Main Results:
- Table 13 lists antigens linked to HDN and their severity.
- Genotype frequencies for major blood groups are detailed.
- Clinical guidance is provided for managing irregular antibodies and predicting HDN risk.
Conclusions:
- Effective antenatal screening for irregular antibodies is crucial for early detection and management of HDN.
- Testing the husband for antigen presence is recommended when an antenatal patient presents with an irregular antibody.
- Improved antenatal care can reduce the morbidity and mortality associated with hemolytic disease of the newborn.
Abstract:
The known antigens associated with hemolytic disease of the newborn along with the degree of severity of the disease caused by each antigen are presented in Table 13. The genotype frequencies for the major blood groups have been presented in the text. It is hoped that this information will help the clinician in managing sensitization to irregular antibodies and in predicting the likelihood of future affected siblings. Proper periodic screening of the antenatal patient for irregular antibodies can alert the physician to a potential problem with hemolytic disease and alert the laboratory so that time is available to find acceptable donors. One should always remember that autologous blood transfusion can be used if time is available to obtain the blood. When the antenatal patient with an irregular antibody presents, the husband should be tested for the presence of the antigen. If present, the physician should determine the severity of the disease that can be caused by this antibody and manage the patient appropriately. It is hoped that with good antenatal care, the morbidity and mortality of hemolytic disease of the newborn can be diminished.